Patient Centricity
Articles, news, blogs, videos that include topics that put the patient first in clinical trials.
Subjects Wants Results
This blog interview with Joseph Kim, Director of Clinical Operations at Shire, offers his take when he mediated a patient panel focused on their experiences participating in a clinical trial at the CBI Patient Centricity Forum.
Providing Results to Volunteers
This peer-review article from CISCRP also discusses clinical trial results for participants in the form of a survey.
Direct-to-Patient Enrollment Strategies
This peer-review article discusses the results of an online outreach campaign for participant enrollment in a clinical trial, versus other recruitment techniques.
Pfizer’s REMOTE Trial Experience
Bringing Trials to the Patient at Home
Social Media Patient Recruitment Success
Thomas Krohn of Lilly Center of Innovation Discusses Patient CentricitySmart Trials, Smarter PatientsExisting Clinical Trial Infrastructure Reveals Alarming Behaviors from Research ParticipantsA New Look at Global Study Volunteer Experiences with Informed ConsentImperatives to Share Trial Results with VolunteersPatient Centric Clinical Research: A Renaissance in the MakingRe-Imagining Clinical Trial Info in a Patient-Centric WayPatient First Approach to Improve Oncology Trials
The Meaning of Patient Centricity
Exisiting Clinical Trials Infrastructure Reveals Alarming Behaviors from Research Subjects
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
